Bill Gates population control with vaccines? Male

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
222
Bill Gates population control with vaccines?

Male Impotence following Gardasil


https://helenlobato.com/2020/01/15/male-impot...-gardasil/

Not surprisingly young males are now reporting adverse events after receiving the Gardasil HPV vaccine. According to Gardasil researcher Lloyd. W. Phillips this includes impotence.

Introduction of Gardasil for boys
In 2012, the Australian Health Minister, Tanya Plibersek, launched the world’s first national human papilloma virus (HPV) immunisation program for boys aged 12–13, beginning from February 2013. It is astounding that an extension of this problematic vaccination program to include boys was given the go-ahead when there had already been serious safety issues associated with the Gardasil vaccination program for girls.

By 2013, when the program to vaccinate boys was commencing, Australia’s database of adverse event notifications (DAEN) had 1,961 reports of adverse events occurring in girls following the cervical cancer vaccination (TGA, 2017). These figures would be much higher if there was a requirement for mandatory reporting of adverse events. If this were the case, the government would take lodged adverse effects seriously and the media would report them. But expanding the market by finding new consumers makes more money for the vaccine industry which is what the Gardasil vaccination program for boys has achieved.

Lloyd W. Phillips explains how the same mechanism that is causing Postural Orthostatic Tachycardia Syndrome (POTS) can cause impotence in males

POTS is currently primarily attributed to Gardasil’s unusually strong nano-particle Aluminium adjuvant, which hyper-activates Antigen Presenting Cells (APCs). These APCs result in both IgE and NON-IgE immune responses. Theses responses may then trigger Mast Cells to produce histamine, and possibly trigger eosinophils to also release their histamine, which may then dilate blood vessels. The same dilating mechanism which is seen in those with POTS or Postural Orthostatic Tachycardia Syndrome may also dilate blood vessels in the penis, thus causing or contributing to varying degrees of erectile dysfunction in a significant number of male children AND ADULTS who receive the Gardasil and especially the Gardasil9 HPV Vaccine, which contains twice the amount of aluminium adjuvant. Morning erections may cease, and an erection during sex may be difficult to maintain.

The burden of infertility in men is unknown
According to the World Health Organisation:

Infertility and subfertility affect a significant proportion of humanity. WHO has calculated that over 10% of women are inflicted. The burden in men is unknown. The overall burden of sub-fertility/infertility is significant, likely underestimated, and has not displayed any decrease over the last 20 years.

Infertility and HPV vaccines
Gayle DeLong who has researched the area of infertility and association to HPV vaccines writes:

Birth rates in the United States have recently fallen. Birth rates per 1000 females aged 25-29 fell from 118 in 2007 to 105 in 2015. One factor may involve the vaccination against the human papillomavirus (HPV).

Gayle De Long’s study represented 8 million 25-29 year old women in the US between 2007 and 2014.

Approximately 60% of the women who did not receive HPV vaccine had been pregnant at least once, whereas only 35% of women who were exposed to the vaccine had conceived. For married women, 75% who did not receive the vaccine were found to conceive while only 50% who received the vaccine had ever been pregnant.

Interference with the natural process of female reproduction begins with the first dose of Gardasil

Vaccinating a female during her Luteal Phase may result in a high risk of an unpredictably high immune response, and a possible life threatening cascade of events. The immune system becomes so compromised that the dormant Epstein Barr Virus that causes Mononucleosis may become virulent.

Read more

Premature ovarian insufficiency-an autoimmune disease

In the BMJ (British Medical Journal) Case Reports authors Deidre Little and Harvey Rodrick Grenville Ward of Australia reported the case of a patient with amenorrhoea who noticed that her usual regular menstrual cycle had changed, becoming irregular and then scant after Gardasil.

The authors explain that it is very rare for the condition known as premature ovarian failure to occur at such an early age and that the annual incidence is 10 per 100,000 between 15 and 29 years of age. Premature ovarian failure is a serious health event for young girls and one that adversely affects their ability to have children.

Dr Little has continued her research into HPV vaccines after having several more patients report to her with what is now called premature ovarian insufficiency. These young women report having infrequent periods which continue to dwindle and finally cease.

Deidre Little is a general practitioner who has reported on seven patients with POF who told her their symptoms came on after their Gardasil vaccination. If there are seven reports from her small town of Bellingen, NSW, Australia then we can expect that there are many other girls suffering the same unnecessary, but serious and life-changing condition after their Gardasil shots.

Celeste McGovern reports

Between 2006 and 2014, the Vaccine Adverse Event Reporting System (VAERS) cited 48 cases of ovarian damage associated with autoimmune reactions in HPV vaccine recipients. Between 2006 and May, 2018, VAERS catalogued other reproductive issues: spontaneous abortion (256 cases), amenorrhea (172 cases), and irregular menstruation (172 cases), all of which are likely under-reported symptoms.

How does this vaccine cause autoimmunity?

The aluminium adjuvant in Gardasil is excessively potent causing sepsis in the body during which time billions of pathogens such as Epstein Barr virus, Herpes virus and Cytomeglovirus along with heavy metals and other toxins liberated into the bloodstream.

Lloyd W. Phillips has studied many girls who have heavy and /or irregular cycles.

In one case, a 24 year old Asian girl who had been ill since she was in her teens, presented with fevers and 10 day cycles. She was subsequently diagnosed with Chronic Active Epstein Barr Virus (CAEBV), and was the only one in the group of over 100 to be diagnosed with EBV in the chronic form. A significant number of pre-teens and teens show symptoms of, or have a confirmed diagnosis of Premature Ovarian Failure, while a much larger number have been diagnosed with Endometriosis.

When infertility is discussed publicly you can bet there is no mention of vaccines and the effect of the powerful adjuvants and added chemicals such as polysorbate 80 or sodium borate have on the recipients’ reproductive systems. We do not know how many women now suffer ovarian insufficiency and how many young men are rendered impotent by these vaccines now commonly given to female for a disease they are unlikely to encounter and increasingly to males for spurious diseases such as head, neck and throat cancers.

Informed consent is the right to know what is in this vaccine and to know adverse events can be expected should it be given.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PPL Reports Strong Q3; Long-Term EPS Growth Up

Updated Category News Views 29

Solid Earnings in a Challenging Market Anytime you start hearing a company like PPL boasting about their quarterly earnings, it's time to sit up straight and pay attention. The utility giant didn’t just match expectations, they beat 'em, clocking in with $0.54 per share in ongoing earnings for Q3 2026, up from $0.48 the previous year. Not a bad step forward if you ask...

Continue Reading
Thryfter Unleashes Livestream Magic at Goodwill Event

Updated Category News Views 89

A Dynamic Shift in Thrift Shopping All eyes might be on Thryfter this November as they drop some serious retail knowledge at the Goodwill CONNECT Conference in Houston. We’re talking about a tech shake-up for Goodwill’s model, thanks to Thryfter's livestream shopping craze that’s poised to weld traditional thrifting with digital reach. The Power of Virtual Thrift...

Continue Reading
RCMA Makeup Makes Bold Retail Move with Ulta.com Debut

Updated Category News Views 25

RCMA Makeup: A Longstanding Industry Insider You know when a brand’s been around the block since the 60s, it’s got staying power. RCMA Makeup’s been a snug fit in the toolbox of professional makeup artists for over six decades. This ain't some fly-by-night operation. They’ve thrived on word of mouth—no flashy ads or promotional stunts. Just rock-solid reputation...

Continue Reading
Encompass Health Faces Uncertain Future with Sea Pines

Updated Category News Views 68

Unexpected Downpour Closes Sea Pines They say when it rains, it pours. That's not just true in life, but as it happens, it's quite literal in Melbourne, Florida. A deluge of biblical proportions forced an immediate lockdown of the Sea Pines Rehabilitation Hospital. Flooded to the gills, this once stalwart institution finds its doors shuttered indefinitely. It's a...

Continue Reading
Home Insurance Depreciation and What it Means for You

Updated Category News Views 17

A Deep Dive into Depreciation's Impact on Home Insurance Folks, if you haven't battled the insurance beast, you're missing out on an unholy mess. Let's talk about something that's been quietly gnawing at homeowners’ wallets—depreciation in home insurance claims. Peggy Schneider, an insurance guru from Kalispell, Montana, lays it all out in HelloNation, and I'm here to...

Continue Reading
CMS 2027 Fee Schedule: Game Changer for SI Joint Procedures

Updated Category News Views 145

CMS's Move: A New Payment Pathway You don't expect bureaucrats to stir things up, but check this out: the CMS 2027 Physician Fee Schedule has done just that by setting a non-facility (office) payment rate for CPT code 27279. This code covers those fiddly, minimally invasive sacroiliac (SI) joint procedures, where you engage bone and get down to real orthopedic business....

Continue Reading
Koozee Boosts Apparel Design with AI Workflows

Updated Category News Views 108

Revolutionizing Apparel Design with AI If you've ever wondered how tech can make an impact on the fashion world, Koozee's latest update provides an eye-opening look. This isn't about following trends—it's about setting them, and Koozee’s making a bold move with its newest platform enhancements. Introducing Freeform Canvas Koozee has launched the Freeform Canvas, a...

Continue Reading
Strategies for Maintaining Water Quality in NH Homes

Updated Category News Views 92

Protect Your Water: Steps to Safe Drinking Imagine turning on your kitchen tap, and instead of refreshing, clean water, you get a murky mystery. Not exactly anyone's dream scenario, right? Enter Sean McGorry and his down-to-earth guide to water quality for New Hampshire homesteaders. It's not rocket science, but the whispers of neglected water systems tell tales of...

Continue Reading
Upright Proton Therapy: New Era for Cancer Care

Updated Category News Views 129

BayCare's Bold Step into Upright Proton Therapy Here's a twist for you—BayCare Health System has rolled out something that's genuinely pushing the envelope in cancer treatment. They've treated their first patient with an upright proton therapy system. Now, talk about innovation that shakes things up. This isn't just any old upgrade; it's a complete revamp of how proton...

Continue Reading
SM Investments Wins Five Golden Arrows: Governance on Point

Updated Category News Views 82

Gold Arrows and Golden Standards What’s in a bunch of gold arrows, you might ask? Well, for SM Investments Corporation, those Five Golden Arrows from the Institute of Corporate Directors aren't just shiny trinkets. They're badges of honor, symbols of a rock-solid governance fortress. For the third year running, they’ve nailed the top spot under the corporate...

Continue Reading

Top 5 Most Recently Viewed Articles

Yale School of Medicine Celebrates Achievements in Research

Updated Category News Views 167

Yale School of Medicine Celebrates Achievements in Research Today, twenty-seven distinguished faculty members from Yale School of Medicine (YSM) were honored for their remarkable contributions to the field of medical research. Recognized as Highly Cited Researchers for the year 2025, these experts are acknowledged for their influential studies that have garnered...

Continue Reading
Saothair Capital Partners Strengthens Portfolio with T BAILEY

Updated Category News Views 399

Saothair Capital Partners Acquires Majority Stake in T BAILEY In a strategic move, Saothair Capital Partners, LLC has completed the acquisition of a majority equity stake in T BAILEY, LLC. This acquisition signals Saothair's commitment to investing in the middle-market manufacturing sector. Known for its extensive experience and focus, Saothair aims to enhance T BAILEY's...

Continue Reading
Semtech's Earnings Report: What to Anticipate This Quarter

Updated Category News Views 114

Semtech's Earnings Report: What Investors Should Expect Semtech (NASDAQ: SMTC) is gearing up to release its latest quarterly earnings report shortly. As anticipation builds, it's crucial for investors to stay informed on what this means for their holdings in the company. Analysts have projected that Semtech will deliver an earnings per share (EPS) of $0.23. Investors are...

Continue Reading
Vistra Energy Faces Challenges After Battery Facility Fire

Updated Category News Views 192

Vistra Energy Stock Takes a Hit Due to Facility Incident Shares of Vistra Energy (NYSE: VST) experienced a decline of 1.4% in early trading today, following reports of a significant fire at a battery facility located at the company’s Moss Landing power plant. This facility, situated in Monterey County, was put into emergency lockdown as authorities evacuated surrounding...

Continue Reading
Compass Therapeutics Elevates Growth with $120 Million Offering

Updated Category News Views 186

Compass Therapeutics Unveils Significant Public Offering Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a dedicated clinical-stage biopharmaceutical company focused on oncology, has excitedly announced the pricing of an upsized public offering. This offering includes 33,290,000 shares of common stock priced at $3.00 each, along with pre-funded warrants for...

Continue Reading